Encuesta sobre el uso de relajantes musculares en Uruguay - SciELO

4. Wierda JMKH, De With APM, Kuizenga K et al. Clinical observations on the neuromuscular blocking action of
Org 9426, a new steroidal non-depolarizing agent. Br J Anaesth 1990; 64: 521.
5. Wierda J, Mark KH, Beaufort A, Kleef U. Preliminary investigations of the clinical pharmacology of three shortacting
non-depolarizing neuromuscular blocking agents, Org 9453, Org 9489, Org 9487. Canadian J Anaesth 1994;
41: 213.
6. Wierda J, Mark KH et al. Time course of action and endotracheal intubating conditiones of Org 9487, a new
short-acting steroidal muscle relaxant; A comparasion with succinylcholine. Anesth Analg 1993; 77: 579.
7. Meistelman C, Plaud B, Donati F. Neuromuscular effects of succinylcholine on the vocal cords and adductor
pollicis muscles. Anesth Analg 1991; 73: 278.
8. Murray DJ, Gergis SD, Metha MP, et al. Rapid neuromuscular blockade: are there alternatives to
succinylcholine? Middle-East J Anesth 1986; 8: 363-9.
9. Miller RD. The priming principle. Anesthesiology 1985; 62: 381.
10. Taboada JA, Rupp SM, Miller RD. Refining the priming principle for vecuronium during rapid-sequence
induction of anesthesia. Anesthesiology 1986; 64: 243.
11. Molbegott L, Baker T. Speed and ease of tracheal intubation: Priming with mivacurium compared with
succinylcholine. Canadian J Anaesth 1995; 42: 780.
12. Naguib M. Different priming techniques, including mivacurium, accelerate the onset of rocuronium. Canadian J
Anaesth 1994; 41: 902.
13. Huemer G, Schwarz S, Gilly H. Pharmacodynamics, Pharmacokinetics, and intubation conditions after priming
with there different doses of vecuronium. Anesth Analg 1995; 80: 538.
14. Jones RM. The priming principle: How does it work and should we be using it? Br J Anaesth 1989; 63: 1.
15. Pace NL. Prevention of succinylcholine myalgias; a meta-analysis. Anesth Analg 1990; 70: 477.
16. Gramstad L, Lilleaasen P. Neuromuscular blocking effects of atracurium, vecuronium, and pancuronium
during bolus and infusion administration. Br J Anaesth 1985; 57: 1052.
17. Goat VA, Feldman SA. The dual action of suxamethonium on the isolated rabbit heart. Anaesthesia 1972; 27:
149.
18. Delphin E, Jackson D, Rothstein P. Use of succinylcholine during elective pediatric anesthesia should be reevaluated.
Anesth Analg 1987; 66: 1190.
19. Schulte-Sasse VU, Eberlein HJ, Schumucker Y et al. Should the use of succinylcholine during pediatric
anesthesia be reevaluated? Anesthesiol Reanim 1993; 18: 13.
20. Rosenberg H, Gronert GA. Intractable cardiac arrest in children given succinylcholine. Anesthesiology 1992;
77: 1054.
21. Donlon JV, Newfield P, Streter F, et al. Implications of masseter spasm after succinylcholine. Anesthesiology
1978; 49: 298.
22. Van Der Spik AFL, Fang WB, Ashton-Miller JA et al. The effects of succynilcholine on mouth opening.
Anesthesiology 1987; 67: 459.
23. Leary NP, Ellis FR. Masseteric muscle spasm as a normal response to suxamethonium. Br J Anaesth 1990;
64: 488.
24. Meakin G, Walker RWM, Dearlove DR. Myotonic and neuromuscular blocking effects of increased doses of
suxamethonium in infantes and children. Br J Anaesth 1990; 65: 816.
25. Lazzell V, Carr A, Lerman J et al. The incidence of masseter muscle rigidity after succinylcholine in infants
and children. Canadian J Anaesth 1994; 41: 475.